108258-54-4

Basic information

• Product Name: METHYL 2,3-DICHLOROBENZOATE
• Synonyms: methyl 2,3-dichloroquinoxaline-6-carboxylate;2,3-dichloro-6-Quinoxalinecarboxylic acid methyl ester
• CAS NO: 108258-54-4
• Molecular Formula: C₁₀H₆Cl₂N₂O₂
• Molecular Weight: 205
• Mol File: 108258-54-4.mol
• Article Data: 6

Chemical Properties

• Melting Point: 117～119℃
• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: METHYL 2,3-DICHLOROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2,3-DICHLOROBENZOATE(108258-54-4)
• EPA Substance Registry System: METHYL 2,3-DICHLOROBENZOATE(108258-54-4)

Safety Data

• Hazardous Substances Data: 108258-54-4(Hazardous Substances Data)

Usage

Description

METHYL 2,3-DICHLOROBENZOATE, with the molecular formula C8H6Cl2O2, is a chemical compound that presents itself as a clear, colorless to pale yellow liquid. It possesses a slightly sweet odor and is recognized for its role as an intermediate in various chemical syntheses.

Uses

Used in Pharmaceutical Industry:
METHYL 2,3-DICHLOROBENZOATE is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the production of different medicinal compounds, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
In the agrochemical sector, METHYL 2,3-DICHLOROBENZOATE serves as an intermediate in the creation of pesticides and other agricultural chemicals. Its involvement in these processes helps to enhance crop protection and contribute to more efficient farming practices.
Used as a Solvent:
METHYL 2,3-DICHLOROBENZOATE is utilized as a solvent in various chemical processes due to its ability to dissolve a wide range of substances. This makes it a versatile component in industries that require solvents for chemical reactions or the manufacturing of products.
Used in Fragrance and Flavoring Industry:
METHYL 2,3-DICHLOROBENZOATE is used as a component in the manufacturing of fragrance and flavoring agents. Its slightly sweet odor and chemical properties make it suitable for incorporation into perfumes, colognes, and food flavorings to enhance their scents and tastes.
Safety Note:
While METHYL 2,3-DICHLOROBENZOATE is considered to have low toxicity, it is imperative to handle it with care and implement proper safety measures during its use to ensure the well-being of individuals and the environment.

Upstream product

• 36692-49-6 Methyl 3,4-diaminobenzoate 
• 354793-04-7 2,3-dioxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid methyl ester 

Relevant articles and documents

Synthesis and Fungicidal Activity of 1,4-Dithiino[2,3-b]quinoxaline-2,3-dicarbonitriles

A series of eleven 1,4-dithiino[2,3-b]quinoxaline-2,3-dicarbonitriles was prepared by reaction of 2,3-dichloroquinoxalines with disodium (Z)-2,3-dimercapto-2-butenedinitrile in N,N-dimethylformamide. These products were tested for in-vitro fungicidal activity by a Minimum Inhibitory Concentration (MIC) method. Several of these compounds showed broad-spectrum fungicidal activity. The activity exhibited by these compounds was greatly dependent upon the substituents of the quinoxaline ring, with the nitro-substituted derivatives showing the higest levels of antifungal activity. None of the compounds prepared, however, showed fungicidal activity comparable to that of the commercial fungicides screened.

Monoacylglycerol Lipase Modulators

Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.

FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY

The present invention relates to certain certain fused tricyclic heteroaryl rings compounds of the Formula (I) (also referred to herein as the "Fused Tricyclic Compounds"), wherein M, Q, U, W, X, Y, Z, R1, R2, and R3, and rings C and D are as herein described. The present invention also provides compositions comprising at least one Fused Tricyclic Compound, and use of such compounds in the treatment of central nervous system diseases or disorders such as Parkinson's disease.